Press Releases

INCLINE VILLAGE, Nev. , June 25, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the Nasdaq 32 nd Investor Program in London , England.  The fireside chat-style of

INCLINE VILLAGE, Nev. , June 24, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the company has appointed Steffen Pietzke , CPA, to the position of controller and chief accounting officer. Mr. Pietzke officially joins the company this week.

INCLINE VILLAGE, Nev. , June 15, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the June 12, 2015 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of June 5, 2015 , the record date.

INCLINE VILLAGE, Nev. , May 27, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the Jefferies 2015 Global Healthcare Conference next week in New York City.  The presentation,

-Net Income Increased 16 percent-

INCLINE VILLAGE, Nev. , April 29, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL, or the Company) (NASDAQ: PDLI) today announced that the Company will release its first quarter 2015 financial results for the period ended March 31, 2015 , on Wednesday, May 6, 2015 , after market close.

INCLINE VILLAGE, Nev. , March 12, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2015 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 5, 2015 , the record date.

INCLINE VILLAGE, Nev. , March 4, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the adjusted conversion rate for the: 3.75% Convertible Senior Notes due May 1, 2015 ( May 2015 Notes), is 174.8506 shares of common stock per $1,000 principal amount or approximately

INCLINE VILLAGE, Nev. , March 3, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the third of three shareholder lawsuits filed in the fall of 2014, was voluntarily dismissed without prejudice. On February 2, 2015 , a securities lawsuit that was

INCLINE VILLAGE, Nev. , Feb. 26, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that the Company will hold its annual meeting of stockholders on Thursday, May 28, 2015 , at 10:00 a.m. Pacific Time for all stockholders of record on April 2, 2015 .

-Annual Revenues Increased 27 Percent During 2014-

INCLINE VILLAGE, Nev. , Feb. 17, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its fourth quarter and full year 2014 financial results for the period ended December 31, 2014 , on Monday, February 23, 2015 , after market close.

INCLINE VILLAGE, Nev. , Feb. 4, 2015 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that John P. McLaughlin , the company's president and chief executive officer, will present at the following upcoming conferences. 2015 BIO CEO & Investor Conference Monday, February 9,

- Dividend Amount of $0.15 per Share per Quarter -

INCLINE VILLAGE, Nev. , Dec. 15, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the December 12, 2014 , regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of December 5, 2014 , the record date.